Instructions for authors
Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease. An international peer-reviewed journal, it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. The journal also provides reviews, viewpoints, commentaries, debates and reports. Although the primary focus is Alzheimer's dementia, the scope encompasses translational research into other neurodegenerative diseases.
Each article type published by Alzheimer's Research & Therapy follows a specific format, as detailed in the corresponding instructions for authors; please choose an article type from the list on the left to view the instructions for authors.
Please note that Commentary, Debate, Editorial, Letter, Meeting report, Review and Viewpoint are usually commissioned, but suggestions for these article types are welcome.
The instructions for authors includes information about preparing a manuscript for submission to Alzheimer's Research & Therapy, criteria for publication and the online submission process. Other relevant information about the journal's policies, the refereeing process and so on can be found in 'About this journal'.
Alzheimer's Research & Therapy publishes the following article types:
- Research articles
- Letters to the editor
- Meeting reports
- Open comments
We use plagiarism detection
This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).
Authors and referees are asked to declare any competing interests.Copyright for original research articles rests with the authors. For more information on copyright of research articles, see our publisher's copyright and license policy. Copyright of all other articles rests with the authors who grant BioMed Central an exclusive license to publish and distribute the Article for the initial 12-months subscription period. For further details, see copyright and license BioMed Central’s copyright and license agreement for articles that are not immediately open access.